Acadia Healthcare Company Inc (ACHC) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock shows strong upward momentum, positive analyst sentiment, and technical indicators supporting a bullish trend. Despite hedge fund selling, the lack of negative news and the company's operational improvements make it an attractive long-term investment.
The technical indicators are bullish: MACD is positively expanding above 0, RSI is neutral at 53.178, and moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot level of 24.755, with resistance levels at 25.786 and 26.424.

Analysts have upgraded the stock with higher price targets, citing operational improvements, enhanced earnings visibility, and better management execution.
The stock has shown strong price momentum, with a 5.83% gain in the regular market session.
Technical indicators support a bullish trend.
Hedge funds are selling the stock, with a significant increase in selling activity (194.77% over the last quarter).
No recent news or congress trading data to provide additional sentiment insights.
No financial data available for the latest quarter.
Analysts are bullish on ACHC. Recent upgrades include Jefferies upgrading to Buy with a price target of $30, Raymond James upgrading to Strong Buy with a target of $39, and RBC Capital raising the price target to $31. Analysts highlight operational improvements, higher EBITDA estimates, and better management execution as key drivers for the upgrades.